跳至主要内容
临床试验/TCTR20230712001
TCTR20230712001已完成2 期

Differences in interleukin-6, tumor necrosis factor, and procalcitonin levels in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) patients with and without secretome supplementation

embaga Penelitian dan Pengabdian Kepada Masyarakat (LPPM) Sebelas Maret University Surakarta0 个研究点目标入组 28 人开始时间: 2023年7月12日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
28

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • 1. Patients diagnosed with acute exacerbation of COPD. Clinical symptoms of COPD exacerbation: worsening of symptoms (increasing shortness of breath, increased amount of sputum, and sputum purulence) compared to daily conditions.
  • 2. Age over 40 years, based on the difference between the day of birth and the last birthday at the time of the study.
  • 3. Willing to participate in the research and sign the informed consent.

排除标准

  • 1. AECOPD patients requiring ICU care and ventilators.
  • 2. COPD patients with pleural effusion.
  • 3. COPD patients with lung cancer.
  • 4. COPD patients with HIV.

研究者

发起方
embaga Penelitian dan Pengabdian Kepada Masyarakat (LPPM) Sebelas Maret University Surakarta

相似试验